Bio Essence Corporation
BIOE
$0.40
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 981.51% | -47.20% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 981.51% | -47.20% | |||
| Cost of Revenue | 719.51% | -54.70% | |||
| Gross Profit | 1,093.53% | -43.18% | |||
| SG&A Expenses | 39.63% | -24.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 267.18% | -38.10% | |||
| Operating Income | 7,100.00% | -76.63% | |||
| Income Before Tax | 7,816.15% | -78.58% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 7,816.15% | -78.30% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 7,816.15% | -78.30% | |||
| EBIT | 7,100.00% | -76.63% | |||
| EBITDA | 7,100.70% | -76.67% | |||
| EPS Basic | 8,933.33% | -81.25% | |||
| Normalized Basic EPS | 8,350.00% | -80.00% | |||
| EPS Diluted | 16,766.67% | -81.25% | |||
| Normalized Diluted EPS | 8,350.00% | -80.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||